The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
Abstract
Through the study of transcriptional activation in response to interferon alpha (IFN-alpha) and interferon gamma (IFN-gamma), a previously unrecognized direct signal transduction pathway to the nucleus has been uncovered: IFN-receptor interaction at the cell surface leads to the activation of kinases of the Jak family that then phosphorylate substrate proteins called STATs (signal transducers and activators of transcription). The phosphorylated STAT proteins move to the nucleus, bind specific DNA elements, and direct transcription. Recognition of the molecules involved in the IFN-alpha and IFN-gamma pathway has led to discoveries that a number of STAT family members exist and that other polypeptide ligands also use the Jak-STAT molecules in signal transduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Signal transducer and activator of transcription 3 (STAT3) belongs to the family of STAT transcription factors which mediate the cellular response to a variety of cytokines and growth factors including IL-6 (6-8”
From STAT3 Contributes to the Mitogenic Response of Hepatocytes during Liver Regeneration (2002) · cites this paper as [6]
In the citing paper
“Specifically, STAT1 and IRF5 have been shown to be involved in polarization and maintenance of an M1 phenotype while STAT6, IRF4, CREB-C/EBPβ, and PPARγ are involved in polarization and maintenance of an M2 phenotype [23–30].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [23]
Citations
Cites
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Kessler, D. S., Veals, S. A., Fu, X. Y., & Levy, D. E. (1990) · Genes & Development · doi:10.1101/gad.4.10.1753 · Cited by 312
Cohen, B., Peretz, D., Vaiman, D., Benech, P., & Chebath, J. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02958.x · Cited by 180
Flagged first, then by citations
Research works printed but not linked: 84
- AGUET, M, MOLECULAR-CLONING AND EXPRESSION OF THE HUMAN INTERFERON-GAMMA RECEPTOR, CELL 55: 273 (1988). · DOI
- ALMENDRAL, J.M., COMPLEXITY OF THE EARLY GENETIC RESPONSE TO GROWTH-FACTORS IN MOUSE FIBROBLASTS, MOLECULAR AND CELLULAR BIOLOGY 8: 2140 (1988).
- 10.1016/0092-8674(93)90415-M · DOI
- BEADLING, C, ISOLATION OF INTERLEUKIN-2-INDUCED IMMEDIATE-EARLY GENES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 2719 (1993).
- BLANAR, M.A., TRANSCRIPTIONAL ACTIVATION OF HLA-DR-ALPHA BY INTERFERON-GAMMA REQUIRES A TRANS-ACTING PROTEIN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 4672 (1988).
- 10.1126/science.7504325 · DOI
- COLAMONICI, O.R., MULTICHAIN STRUCTURE OF THE IFN-ALPHA RECEPTOR ON HEMATOPOIETIC-CELLS, JOURNAL OF IMMUNOLOGY 148: 2126 (1992). · DOI
- DALE, T.C., OVERLAPPING SITES FOR CONSTITUTIVE AND INDUCED DNA-BINDING FACTORS INVOLVED IN INTERFERON-STIMULATED TRANSCRIPTION, EMBO JOURNAL 8: 831 (1989). · DOI
- DALE, T.C., RAPID ACTIVATION BY INTERFERON-ALPHA OF A LATENT DNA-BINDING PROTEIN PRESENT IN THE CYTOPLASM OF UNTREATED CELLS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 86: 1203 (1989).
- 10.1126/science.1496402 · DOI
- DECKER, T, INTERACTIONS OF ALPHA-INTERFERON AND GAMMA-INTERFERON IN THE TRANSCRIPTIONAL REGULATION OF THE GENE ENCODING A GUANYLATE-BINDING PROTEIN, EMBO JOURNAL 8: 2009 (1989). · DOI
- DECKER, T, CYTOPLASMIC ACTIVATION OF GAF, AN IFN-GAMMA-REGULATED DNA-BINDING FACTOR, EMBO JOURNAL 10: 927 (1991). · DOI
- FIRMBACHKRAFT, I, TYK2, PROTOTYPE OF A NOVEL CLASS OF NONRECEPTOR TYROSINE KINASE GENES, ONCOGENE 5: 1329 (1990).
- 10.1126/science.1650499 · DOI
- 10.1093/nar/9.23.6505 · DOI
- FRIEDMAN, R.L., TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION OF INTERFERON-INDUCED GENE-EXPRESSION IN HUMAN-CELLS, CELL 38: 745 (1984). · DOI
- 10.1016/0092-8674(92)90106-M · DOI
- FU, X.Y., ISGF3, THE TRANSCRIPTIONAL ACTIVATOR INDUCED BY INTERFERON-ALPHA, CONSISTS OF MULTIPLE INTERACTING POLYPEPTIDE-CHAINS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 87: 8555 (1990).
- FU, X.Y., THE PROTEINS OF ISGF-3, THE INTERFERON ALPHA-INDUCED TRANSCRIPTIONAL ACTIVATOR, DEFINE A GENE FAMILY INVOLVED IN SIGNAL TRANSDUCTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 7840 (1992).
- GARRER, M.M., NUCLEIC ACIDS RES 9: 3047 (1981). · DOI
- 10.1126/science.1898992 · DOI
- GREENBERG, M.E., NERVE GROWTH-FACTOR AND EPIDERMAL GROWTH-FACTOR INDUCE RAPID TRANSIENT CHANGES IN PROTO-ONCOGENE TRANSCRIPTION IN PC12 CELLS, JOURNAL OF BIOLOGICAL CHEMISTRY 260: 14101 (1985). · DOI
- 10.1038/311433a0 · DOI
- HARADA, H, STRUCTURALLY SIMILAR BUT FUNCTIONALLY DISTINCT FACTORS, IRF-1 AND IRF-2, BIND TO THE SAME REGULATORY ELEMENTS OF IFN AND IFN-INDUCIBLE GENES, CELL 58: 729 (1989). · DOI
- HARPUR, A.G., ONCOGENE 7: 895 (1992).
- HEMMI, S, A NOVEL MEMBER OF THE INTERFERON RECEPTOR FAMILY COMPLEMENTS FUNCTIONALITY OF THE MURINE INTERFERON-GAMMA RECEPTOR IN HUMAN-CELLS, CELL 76: 803 (1994). · DOI
- IGARASHI, K, IN-VITRO ACTIVATION OF A TRANSCRIPTION FACTOR BY GAMMA-INTERFERON REQUIRES A MEMBRANE-ASSOCIATED TYROSINE KINASE AND IS MIMICKED BY VANADATE, MOLECULAR AND CELLULAR BIOLOGY 13: 3984 (1993).
- Improta, T., Proceedings of the National Academy of Sciences of the United States of America 91: 4776 (1994).
- JOHN, J, ISOLATION AND CHARACTERIZATION OF A NEW MUTANT HUMAN CELL-LINE UNRESPONSIVE TO ALPHA-INTERFERONS AND BETA-INTERFERONS, MOLECULAR AND CELLULAR BIOLOGY 11: 4189 (1991).
- KAHN, K.D., PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 6806 (1993).
- KANNO, Y, THE GENOMIC STRUCTURE OF THE MURINE ICSBP GENE REVEALS THE PRESENCE OF THE GAMMA INTERFERON-RESPONSIVE ELEMENT, TO WHICH AN ISGF3-ALPHA SUBUNIT (OR SIMILAR) MOLECULE BINDS, MOLECULAR AND CELLULAR BIOLOGY 13: 3951 (1993).
- KESSLER, D.S., 2 INTERFERON-INDUCED NUCLEAR FACTORS BIND A SINGLE PROMOTER ELEMENT IN INTERFERON-STIMULATED GENES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 8521 (1988).
- 10.1126/science.1708916 · DOI
- 10.1126/science.7694370 · DOI
- 10.1126/science.8378773 · DOI
- LARNER, A.C., TRANSCRIPTIONAL INDUCTION BY INTERFERON - NEW PROTEIN(S) DETERMINE THE EXTENT AND LENGTH OF THE INDUCTION, JOURNAL OF BIOLOGICAL CHEMISTRY 261: 453 (1986). · DOI
- LARNER, A.C., TRANSCRIPTIONAL INDUCTION OF 2 GENES IN HUMAN-CELLS BY BETA-INTERFERON, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 81: 6733 (1984).
- LEE, T.H., ISOLATION AND CHARACTERIZATION OF 8 TUMOR NECROSIS FACTOR-INDUCED GENE-SEQUENCES FROM HUMAN FIBROBLASTS, MOLECULAR AND CELLULAR BIOLOGY 10: 1982 (1990).
- LEVY, D, NEW BIOL 2: 923 (1990).
- LEVY, D.E., SYNERGISTIC INTERACTION BETWEEN INTERFERON-ALPHA AND INTERFERON-GAMMA THROUGH INDUCED SYNTHESIS OF ONE SUBUNIT OF THE TRANSCRIPTION FACTOR ISGF3, EMBO JOURNAL 9: 1105 (1990). · DOI
- LEVY, D.E., CYTOPLASMIC ACTIVATION OF ISGF3, THE POSITIVE REGULATOR OF INTERFERON-ALPHA-STIMULATED TRANSCRIPTION, RECONSTITUTED INVITRO, GENES & DEVELOPMENT 3: 1362 (1989). · DOI
- LEVY, D.E., INTERFERON-INDUCED NUCLEAR FACTORS THAT BIND A SHARED PROMOTER ELEMENT CORRELATE WITH POSITIVE AND NEGATIVE TRANSCRIPTIONAL CONTROL, GENES & DEVELOPMENT 2: 383 (1988). · DOI
- Levy, D. E., Interferon: Principles and Medical Applications: 161 (1992).
- LEW, D.J., ALPHA-INTERFERON AND GAMMA INTERFERON STIMULATE TRANSCRIPTION OF A SINGLE GENE THROUGH DIFFERENT SIGNAL TRANSDUCTION PATHWAYS, MOLECULAR AND CELLULAR BIOLOGY 9: 5404 (1989).
- LEW, D.J., OVERLAPPING ELEMENTS IN THE GUANYLATE-BINDING PROTEIN GENE PROMOTER MEDIATE TRANSCRIPTIONAL INDUCTION BY ALPHA AND GAMMA INTERFERONS, MOLECULAR AND CELLULAR BIOLOGY 11: 182 (1991).
- LUSTER, A.D., GAMMA-INTERFERON TRANSCRIPTIONALLY REGULATES AN EARLY-RESPONSE GENE CONTAINING HOMOLOGY TO PLATELET PROTEINS, NATURE 315: 672 (1985). · DOI
- MAO, C, MUTANT HUMAN-CELLS DEFECTIVE IN INDUCTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II GENES BY INTERFERON-GAMMA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 2880 (1993).
- MCKENDRY, R, HIGH-FREQUENCY MUTAGENESIS OF HUMAN-CELLS AND CHARACTERIZATION OF A MUTANT UNRESPONSIVE TO BOTH ALPHA INTERFERON AND GAMMA INTERFERON, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 88: 11455 (1991).
- MIRKOVITCH, J, MAPPING OF RNA-POLYMERASE ON MAMMALIAN GENES IN CELLS AND NUCLEI, MOLECULAR BIOLOGY OF THE CELL 3: 1085 (1992). · DOI
- MIYAMOTO, M, REGULATED EXPRESSION OF A GENE ENCODING A NUCLEAR FACTOR, IRF-1, THAT SPECIFICALLY BINDS TO IFN-BETA-GENE REGULATORY ELEMENTS, CELL 54: 903 (1988). · DOI
- MULLER, M, COMPLEMENTATION OF A MUTANT-CELL LINE - CENTRAL ROLE OF THE 91-KDA POLYPEPTIDE OF ISGF3 IN THE INTERFERON-ALPHA AND INTERFERON-GAMMA SIGNAL-TRANSDUCTION PATHWAYS, EMBO JOURNAL 12: 4221 (1993). · DOI · Paper page
- MULLER, M, THE PROTEIN-TYROSINE KINASE JAK1 COMPLEMENTS DEFECTS IN INTERFERON-ALPHA/BETA AND INTERFERON-GAMMA SIGNAL-TRANSDUCTION, NATURE 366: 129 (1993). · DOI
- MURDOCH, G.H., EPIDERMAL GROWTH-FACTOR RAPIDLY STIMULATES PROLACTIN GENE-TRANSCRIPTION, NATURE 300: 192 (1982). · DOI
- OVERDUIN, M, 3-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY-2 DOMAIN OF C-ABL, CELL 70: 697 (1992). · DOI
- PEARSE, R.N., INTERFERON-GAMMA-INDUCED TRANSCRIPTION OF THE HIGH-AFFINITY FC RECEPTOR FOR IGG REQUIRES ASSEMBLY OF A COMPLEX THAT INCLUDES THE 91-KDA SUBUNIT OF TRANSCRIPTION FACTOR ISGF3, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 4314 (1993).
- PELLEGRINI, S, USE OF A SELECTABLE MARKER REGULATED BY ALPHA INTERFERON TO OBTAIN MUTATIONS IN THE SIGNALING PATHWAY, MOLECULAR AND CELLULAR BIOLOGY 9: 4605 (1989).
- PINE, R, PURIFICATION AND CLONING OF INTERFERON-STIMULATED GENE FACTOR-2 (ISGF2) - ISGF2 (IRF-1) CAN BIND TO THE PROMOTERS OF BOTH BETA-INTERFERON-STIMULATED AND INTERFERON-STIMULATED GENES BUT IS NOT A PRIMARY TRANSCRIPTIONAL ACTIVATOR OF EITHER, MOLECULAR AND CELLULAR BIOLOGY 10: 2448 (1990).
- PORTER, ACG, INTERFERON RESPONSE ELEMENT OF THE HUMAN GENE-6-16, EMBO JOURNAL 7: 85 (1988). · DOI
- REICH, N, INTERFERON-INDUCED TRANSCRIPTION OF A GENE ENCODING A 15-KDA PROTEIN DEPENDS ON AN UPSTREAM ENHANCER ELEMENT, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 84: 6394 (1987).
- 10.1126/science.8378774 · DOI
- RUTHERFORD, M.N., INTERFERON-INDUCED BINDING OF NUCLEAR FACTORS TO PROMOTER ELEMENTS OF THE 2-5A SYNTHETASE GENE, EMBO JOURNAL 7: 751 (1988). · DOI
- 10.1126/science.8397445 · DOI
- SCHINDLER, C, PROTEINS OF TRANSCRIPTION FACTOR ISGF-3 - ONE GENE ENCODES THE 91-KDA AND 84-KDA ISGF-3 PROTEINS THAT ARE ACTIVATED BY INTERFERON-ALPHA, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 89: 7836 (1992).
- 10.1126/science.1496401 · DOI · Paper page
- SHIRAYOSHI, Y, INTERFERON-INDUCED TRANSCRIPTION OF A MAJOR HISTOCOMPATIBILITY CLASS-I GENE ACCOMPANIES BINDING OF INDUCIBLE NUCLEAR FACTORS TO THE INTERFERON CONSENSUS SEQUENCE, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 85: 5884 (1988).
- 10.1016/0092-8674(94)90357-3 · DOI · Paper page
- 10.1126/science.1281555 · DOI
- 10.1126/science.7690989 · DOI · Paper page
- SHUAL, K, POLYPEPTIDE SIGNALING TO THE NUCLEUS THROUGH TYROSINE PHOSPHORYLATION OF JAK AND STAT PROTEINS, NATURE 366: 580 (1993). · DOI
- SILVENNOINEN, O, INTERFERON-INDUCED NUCLEAR SIGNALING BY JAK PROTEIN-TYROSINE KINASES, NATURE 366: 583 (1993). · DOI
- SILVENNOINEN, O, STRUCTURE OF THE MURINE JAK2 PROTEIN-TYROSINE KINASE AND ITS ROLE IN INTERLEUKIN-3 SIGNAL-TRANSDUCTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 90: 8429 (1993).
- 10.1126/science.8378775 · DOI
- SIMS, S. H., MOLECULAR AND CELLULAR BIOLOGY 13: 690 (1993).
- SOH, J, IDENTIFICATION AND SEQUENCE OF AN ACCESSORY FACTOR REQUIRED FOR ACTIVATION OF THE HUMAN INTERFERON-GAMMA RECEPTOR, CELL 76: 793 (1994). · DOI
- UZE, G, GENETIC TRANSFER OF A FUNCTIONAL HUMAN INTERFERON-ALPHA RECEPTOR INTO MOUSE CELLS - CLONING AND EXPRESSION OF ITS CDNA, CELL 60: 225 (1990). · DOI
- VEALS, S.A., SUBUNIT OF AN ALPHA-INTERFERON-RESPONSIVE TRANSCRIPTION FACTOR IS RELATED TO INTERFERON REGULATORY FACTOR AND MYB FAMILIES OF DNA-BINDING PROTEINS, MOLECULAR AND CELLULAR BIOLOGY 12: 3315 (1992).
- 10.1016/0092-8674(92)90105-L · DOI
- Wakao, H., EMBO J. 13: 2182 (1994). · DOI
- WATLING, D, COMPLEMENTATION BY THE PROTEIN-TYROSINE KINASE JAK2 OF A MUTANT-CELL LINE DEFECTIVE IN THE INTERFERON-GAMMA SIGNAL-TRANSDUCTION PATHWAY, NATURE 366: 166 (1993). · DOI
- WILKS, A.F., 2 NOVEL PROTEIN-TYROSINE KINASES, EACH WITH A 2ND PHOSPHOTRANSFERASE-RELATED CATALYTIC DOMAIN, DEFINE A NEW CLASS OF PROTEIN-KINASE, MOLECULAR AND CELLULAR BIOLOGY 11: 2057 (1991).
- WILKS, A.F., 2 PUTATIVE PROTEIN-TYROSINE KINASES IDENTIFIED BY APPLICATION OF THE POLYMERASE CHAIN-REACTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 86: 1603 (1989).
- WITTHUHN, B.A., JAK2 ASSOCIATES WITH THE ERYTHROPOIETIN RECEPTOR AND IS TYROSINE-PHOSPHORYLATED AND ACTIVATED FOLLOWING STIMULATION WITH ERYTHROPOIETIN, CELL 74: 227 (1993). · DOI
- Yamamato K. Molecular and Cellular Biology in press.
- Zhong, Z., Proceedings of the National Academy of Sciences of the United States of America 91: 4806 (1994).
Cited by
Sorted by citations
Items 601–700 of 1,078
Hepatitis C Virus NS5A Disrupts STAT1 Phosphorylation and Suppresses Type I Interferon Signaling
Kumthip, K., Chusri, P., Jilg, N., Zhao, L., Fusco, D., Zhao, H., Goto, K., Cheng, D., Schaefer, E. A. K., Zhang, L.-L., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00533-12 · Cited by 82
“This complex translocates into the nucleus and binds the IFNstimulated response element (ISRE) in IFN-stimulated gene (ISG) promoters, leading to the upregulation of IFN effector proteins such as the double-stranded RNA-activated protein kinase (PKR), the 2=,5=-oligoadenylate synthetase (OAS), and the MxA (myxovirus r…”
BackgroundLukosz, M., Jakob, S., Büchner, N., Zschauer, T.-C., Altschmied, J., & Haendeler, J. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2609 · Cited by 83
“There it binds to DNA and activates transcription (40).”
Making a grade: Sonic Hedgehog signalling and the control of neural cell fate
Briscoe, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.12 · Cited by 81
“These studies, together with elegant biochemical and molecular experiments from the labs of Darnell, Ihle and co-workers in the USA, were the foundation of what is now referred to as the JAK/STAT signalling pathway (Darnell et al, 1994; Ihle, 1995).”
BackgroundLittle, H., Rorick, N. K., Su, L.-I., Baldock, C., Malhotra, S., Jowitt, T., Gakhar, L., Ramaswamy, S., Schutte, B. C., Dixon, M. J., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn381 · Cited by 80
“Three IRF consensus binding sites containing this sequence were synthesized; ISRE1: GAAANNGAAANN; IRF-E: GAAA/C /TGAAA /C /C and ISRE3: /GNGAAANNGAAACT (29,30) and used in electrophoretic mobility shift assays with the His-tagged IRF6-DBD.”
MethodCucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells.
van Kester, M., Out-Luiting, J., Borne, P. V. D., Willemze, R., Tensen, C., & Vermeer, M. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701246 · Cited by 82
JAK inhibitors: Ten years after
Spinelli, F. R., Meylan, F., O’Shea, J. J., & Gadina, M. (2021) · European Journal of Immunology · doi:10.1002/eji.202048922 · Cited by 91
Iwata, S., Mikami, Y., Sun, H., Brooks, S. R., Jankovic, D. L., Hirahara, K., Onodera, A., Shih, H., Kawabe, T., Jiang, K., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.05.005 · Cited by 89
“IFN-g is a specialized factor that acts through a distinct receptor and SDTF, a STAT1 homodimer (Darnell et al., 1994).”
Eisele, N. A., & Anderson, D. M. (2011) · Journal of Pathogens · doi:10.4061/2011/249802 · Cited by 91
“IFN-γ signaling through the IFN-γ receptor stimulates macrophages to upregulate bactericidal effector function against all three Francisella strains [55].”
BackgroundReview of Hepatitis B Therapeutics
Bhattacharya, D., & Thio, C. (2010) · Clinical Infectious Diseases · doi:10.1086/656624 · Cited by 81
“Interferon alfa enhances the innate immune response by binding to the type 1 interferon receptor, resulting in activation of the Jak-Stat pathway [4] and up-regulation of multiple interferon-stimulated genes, which limit viral dissemination.”
Novel immunosuppressive agents in kidney transplantation
Cooper, J. E., & Wiseman, A. C. (2010) · Clinical Nephrology · doi:10.5414/cnp73333 · Cited by 48
“Receptor-mediated activation of JAKs results in autophosphorylation of the receptor and recruitment of signal transducers and activators of transcription (STATs) which in turn are transported to the nucleus where they regulate gene expression [13, 57].”
BackgroundRegulation of STAT3-mediated signaling by LMW-DSP2
Sekine, Y., Tsuji, S., Ikeda, O., Sato, N., Aoki, N., Aoyama, K., Sugiyama, K., & Matsuda, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209578 · Cited by 78
“4 The signal transducer and activator of transcription (STAT) is known to mediate cell proliferation, differentiation and survival in immune responses, hematopoiesis, neurogenesis and other biological processes (Darnell et al.,1994; Ihle,1996; O’Shea,1997).”
BackgroundKumar, A., Kumar, A., Michael, P., Brabant, D., Parissenti, A. M., Ramana, C. V., Xu, X., & Parrillo, J. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508416200 · Cited by 75
Yang, X. Q., Feng, W., Wang, R., Yang, F., Wang, L., Chen, S., Ru, Y., Cheng, T., & Zheng, G. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1412910 · Cited by 101
Kim, B., Yi, E. H., & Ye, S. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0795-8 · Cited by 81
Farmer, L., Ledeboer, M., Hoock, T., Arnost, M., Bethiel, R. S., Bennani, Y., Black, J., Brummel, C. L., Chakilam, A. R., Dorsch, W., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00301 · Cited by 80
Zhang, J., Li, Y., & Hu, Y. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.02.033 · Cited by 81
“IRF9 is a component of the tertiary complex interferonestimulated gene factor (ISGF3), which is formed in IFN-treated cells to stimulate transcription [32], and it participates in the antiviral effect of Type I IFN.”
BackgroundMicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3
Lu, Y., Yue, X., Cui, Y., Zhang, J., & Wang, K. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.157 · Cited by 80
Nowak, M. D., Arredouani, M., Tun-Kyi, A., Schmidt-Wolf, I., Sanda, M., Balk, S., & Exley, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011311 · Cited by 80
Role of Schlafen 2 (SLFN2) in the Generation of Interferon α-induced Growth Inhibitory Responses
Katsoulidis, E., Carayol, N., Woodard, J., Konieczna, I., Majchrzak-Kita, B., Jordan, A., Sassano, A., Eklund, E. A., Fish, E. N., & Platanias, L. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030445 · Cited by 76
Pro-inflammatory cytokines and HIV-1 synergistically enhance CXCL10 expression in human astrocytes
Williams, R., Dhillon, N., Hegde, S., Yao, H.-H., Peng, F., Callen, S. E., Chebloune, Y., Davis, R., & Buch, S. (2009) · Glia · doi:10.1002/glia.20801 · Cited by 80
“IFN-g activates the JAK/STAT pathway through the a- and b-subunits (Darnell et al., 1994; Lackmann et al., 1998; Lee et al., 2005; Shapiro et al., 1998) leading to the activation of JAK1 and JAK2 kinases followed by tyrosine phosphorylation of STAT1 (Brasier, 2006; Calzado et al., 2007; Darnell et…”
InfluentialHellsten, R., Johansson, M., Dahlman, A., Dizeyi, N., Sterner, O., & Bjartell, A. S. (2007) · The Prostate · doi:10.1002/pros.20699 · Cited by 84
JAK inhibitors for rheumatoid arthritis
Kubo, S., Nakayamada, S., & Tanaka, Y. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2199919 · Cited by 79
“dimerizes and translocates to the nucleus, where it initiates cytokine signaling [14].”
BackgroundOsthole inhibits triple negative breast cancer cells by suppressing STAT3
Dai, X., Yin, C., Zhang, Y., Guo, G.-L., Zhao, C., Wang, O., Xiang, Y., Zhang, X., & Liang, G. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0992-z · Cited by 89
“STAT3 is a member of STAT transcription factors that mediate many aspects of immunity, proliferation, apoptosis and differentiation [17, 18].”
BackgroundImmunomodulatory Cytokines as Therapeutic Agents for Melanoma
Nicholas, C., & Lesinski, G. B. (2011) · Immunotherapy · doi:10.2217/imt.11.45 · Cited by 87
Mesquita, F. F., Gontijo, J. A. R., & Boer, P. A. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp505 · Cited by 80
Sow, F. B., Alvarez, G. R., Gross, R. P., Satoskar, A. R., Schlesinger, L. S., Zwilling, B. S., & Lafuse, W. P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1208719 · Cited by 83
“IFN- induces gene expression by signaling through the JAK-STAT pathway [3, 4], leading to translocation of STAT1 to the nucleus, where it induces expression of IFN- -responsive genes [5].”
BackgroundYin, J., Gardner, C. L., Burke, C., Ryman, K., & Klimstra, W. (2009) · Journal of Virology · doi:10.1128/jvi.01209-09 · Cited by 79
“the noncytolytic clearance of SINV mediated by IFN- (which also signals through the STAT1 pathway [14]) released by T cells (4, 7).”
BackgroundKroczyńska, B., Kaur, S., Katsoulidis, E., Majchrzak-Kita, B., Sassano, A., Kozma, S. C., Fish, E. N., & Platanias, L. C. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01537-08 · Cited by 73
Grzegorczyk, M., Husmeier, D., Edwards, K., Ghazal, P., & Millar, A. (2008) · Bioinform. · doi:10.1093/bioinformatics/btn367 · Cited by 79
“To assist the elucidation of regulatory network structures, probabilistic machine learning methods based on Bayesian networks can be employed, as proposed in the seminal paper by Friedman et al. (2000). In a nutshell, the idea is to simplify the mathematical description of the biological system by replacing coupled di…”
MethodInfluentialZurney, J., Howard, K. E., & Sherry, B. (2007) · Journal of Virology · doi:10.1128/jvi.01172-07 · Cited by 68
“ISGF3 complexes translocate to the nucleus and initiate the transcription of many ISGs, including ISG561 and the transcription factor IRF7, leading to the induction of an antiviral state (12).”
BackgroundCen, L., Luo, J.-M., Zhang, C., Fan, Y., Song, Y., So, K., van Rooijen, N., Pang, C. P., Lam, D. S. C., & Cui, Q. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0791 · Cited by 82
Gartsbein, M., Alt, A., Hashimoto, K., Nakajima, K., Kuroki, T., & Tennenbaum, T. (2006) · Journal of Cell Science · doi:10.1242/jcs.02744 · Cited by 81
“Although the role of tyrosine phosphorylation as an essential step for activation of STAT3 is well established (Darnell et al., 1994; Levy and Darnell, 2002), the precise role of a single serine phosphorylation event, such as the one associated with the activation of Ser727 in STAT3, was not known.”
BackgroundKrischuns, T., Günl, F., Henschel, L., Binder, M., Willemsen, J., Schloer, S., Rescher, U., Gerlt, V., Zimmer, G., Nordhoff, C., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02229 · Cited by 83
“Secreted IFNα/β bind to the interferon-α/β receptor on neighboring cells resulting in STAT1/2 phosphorylation by the receptor-associated Jak/Tyk kinases (8).”
BackgroundMolecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy
Ahmad, S., Bhatia, K., Kannan, A., & Gangwani, L. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s33122 · Cited by 78
Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness
Sung, P. S., Cheon, H., Cho, C. H., Hong, S.-H., Park, D. Y., Seo, H.-I., Park, S., Yoon, S. K., Stark, G. R., & Shin, E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513341112 · Cited by 84
“This transcription factor, IFN-stimulated gene factor 3 (ISGF3), induces the expression of hundreds of ISGs (18, 19).”
BackgroundSelf-citationWen, W. X., Liang, W. P., Wu, J., Kowolik, C. M., Buettner, R., Scuto, A., Hsieh, M.-Y., Hong, H., Brown, C. E., Forman, S. J., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0077 · Cited by 88
“STAT3 is predominantly located in the cytoplasm in an inactive form, but is activated by phosphorylation at Tyr705 by the Janus family kinases (JAK) (25).”
Wang, S., Chi, X., Wei, H., Chen, Y., Chen, Z., Huang, S., & Chen, J. (2014) · Journal of Virology · doi:10.1128/jvi.00126-14 · Cited by 79
“Although it is well recognized that the JAK/STAT pathway plays crucial roles in type I, II, and III IFN-dependent transcription of ISGs (47), the regulation of mRNA translation for these IFN-sensitive genes remains elusive.”
BackgroundZhang, Q., Gong, R., Qu, J., Zhou, Y., Liu, W., Chen, M., Liu, Y., Zhu, Y., & Wu, J. (2011) · Journal of Virology · doi:10.1128/jvi.00688-11 · Cited by 74
Katsoulidis, E., Mavrommatis, E., Woodard, J., Shields, M. A., Sassano, A., Carayol, N., Sawicki, K. T., Munshi, H. G., & Platanias, L. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151076 · Cited by 91
Ju, S. M., Song, H. Y., Lee, S. J., Seo, W. Y., Sin, D. H., Goh, A. R., Kang, Y., Kang, I.-J., Won, M., Yi, J., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.137 · Cited by 75
Bose, R., Maurmann, L., Mishur, R. J., Yasui, L., Gupta, S., Grayburn, W. S., Hofstetter, H., & Salley, T. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0803094105 · Cited by 78
Physical and functional interactions between STAT3 and KAP1
Tsuruma, R., Ohbayashi, N., Kamitani, S., Ikeda, O., Sato, N., Muromoto, R., Sekine, Y., Oritani, K., & Matsuda, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210952 · Cited by 77
Mirmohammadsadegh, A., Hassan, M., Bardenheuer, W., Marini, A., Gustrau, A., Nambiar, S., Tannapfel, A., Bojar, H., Ruzicka, T., & Hengge, U. R. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700385 · Cited by 72
Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
Zhu, H.-Z., Butera, M., Nelson, D., & Liu, C. (2005) · Virology Journal · doi:10.1186/1743-422x-2-80 · Cited by 78
“We further analyzed the expression of ISGs using a RTPCR approach.”
BackgroundInfluentialImmune checkpoint inhibitors in colorectal cancer: limitation and challenges
Yan, S., Wang, W., Feng, Z., Xue, J., Liang, W., Wu, X., Tan, Z., Zhang, X., Zhang, S., Li, X., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403533 · Cited by 83
The long non-coding RNA LUCAT1 is a negative feedback regulator of interferon responses in humans
Agarwal, S., Vierbuchen, T., Ghosh, S., Chan, J., Jiang, Z., Kandasamy, R. K., Ricci, E. P., & Fitzgerald, K. A. (2020) · Nature Communications · doi:10.1038/s41467-020-20165-5 · Cited by 82
Zhang, X., Zhao, Y., Zhu, X., Guo, Y., Yang, Y., Jiang, Y., & Liu, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27450 · Cited by 84
“Darnell, Kerr, and Stark (1994) found that IFN‐γ and LPS promote the activation of M1 macrophages, which is mediated by STAT1.”
BackgroundAloperine induces G2/M phase cell cycle arrest and apoptosis in HCT116 human colon cancer cells
Zhang, L., ZHENG, Y., Deng, H., Liang, L., & Peng, J. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1718 · Cited by 81
“Stat proteins are involved in the regulation of fundamental cell processes, such as cell growth, differentiation, and survival (30).”
Ambjørn, M., Ejlerskov, P., Liu, Y., Lees, M. J., Jäättelä, M., & Issazadeh‐Navikas, S. (2012) · Autophagy · doi:10.4161/auto.22831 · Cited by 81
TYK2 Kinase Activity Is Required for Functional Type I Interferon Responses In Vivo
Prchal‐Murphy, M., Semper, C., Lassnig, C., Wallner, B., Gausterer, C., Ingeborg, T., Kobolák, J., Müller, S., Kolbe, T., Karaghiosoff, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039141 · Cited by 75
“canonical – JAK-STAT signalling pathway [3].”
Díaz, T., Navarro, A., Ferrer, G., Gel, B., Gaya, A., Artells, R., Bellosillo, B., García-García, M., Serrano, S., Martínez, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018856 · Cited by 77
“The JAK2/STAT5 pathway is a common signaling pathway used by many cytokines that regulate target gene expression related to cell survival, proliferation, angiogenesis, and immune evasion [2].”
BackgroundImplication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities
Carthagéna, L., Parise, M. C., Ringeard, M., Chelbi‐Alix, M. K., Hazan, U., & Nisole, S. (2008) · Retrovirology · doi:10.1186/1742-4690-5-59 · Cited by 70
“In order to verify if non-human primate cells are responsive to human IFN treatment, we looked at Stat1 phosphorylation, which is an early post-receptor signaling element of both type I and type II IFN pathways, and can thus serve as a positive-indicator of IFN signaling [26].”
BackgroundIFN- γ Therapy of Tuberculosis and Related Infections
Reljić, R. (2007) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.0103 · Cited by 72
“Elucidation of the IFN-(cid:2) action led to the discovery of the Jak-Stat signaling pathway, 5 which is used also by numerous other cytokines.”
Paeonol attenuates TNBS-induced colitis by inhibiting NF-κB and STAT1 transactivation
Ishiguro, K., Ando, T., Maeda, O., Hasegawa, M., Kadomatsu, K., Ohmiya, N., Niwa, Y., Xavier, R. J., & Goto, H. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.07.002 · Cited by 74
Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54
Terenzi, F., Pal, S., & Sen, G. C. (2005) · Virology · doi:10.1016/j.virol.2005.06.011 · Cited by 67
“IFN, on the other hand, induces the same genes using the same cis-element, ISRE, but a different transcription factor, ISGF-3, that is composed of IRF-9, STAT1 and STAT2 (Darnell et al., 1994; Stark et al., 1998; Levy and Darnell, 2002).”
Yang, C.-H., Murti, A., & Pfeffer, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503120200 · Cited by 77
Parsons, K. S., Hsu, A., & Wark, P. A. B. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12218 · Cited by 75
Qin, S., & Zhang, C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00838-12 · Cited by 78
“To examine this possibility, we used a dominant negative form of STAT3 (dnSTAT3) in which the Y705 residue was mutated to phenylalanine, thereby preventing its phosphorylation and activation (7, 13).”
MethodLee, Y. K., Shanafelt, T. D., Bone, N. D., Strege, A. K., Jelinek, D. F., & Kay, N. E. (2005) · Leukemia · doi:10.1038/sj.leu.2403667 · Cited by 125
Interferon Regulatory Factor 9 Structure and Regulation
Paul, A., Tang, T., & Ng, S. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01831 · Cited by 90
“ISGF3 will translocate into the nucleus and binds to the promoter region of interferon-stimulated response element (ISRE) to activate the transcription of ISGs (37).”
BackgroundVelloso, F. J., Bianco, A. F. R., Farias, J. O., Torres, N., Ferruzo, P. Y. M., Anschau, V., Jesus-Ferreira, H. C., Chang, T., Sogayar, M. C., Zerbini, L. F., et al. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s142154 · Cited by 94
“tutively associated with the receptor), and STATs (latent cytoplasmic transcription factors).(162) JAKs are cytoplasmic TKs”
Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres
Mukthavaram, R., Ouyang, X., Saklecha, R., Jiang, P., Nomura, N., Pingle, S. C., Guo, F., Makale, M., & Kesari, S. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0627-5 · Cited by 70
“Instead, they found reduced protein expression of another Bcl-2-family protein, Mcl-1 which is known to be modulated by STAT3 [13].”
Targeting the PIAS1 SUMO ligase pathway to control inflammation
Liu, B., & Shuai, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.07.008 · Cited by 70
Tan, J., Qiao, W., Wang, J., Xu, F.-W., Li, Y., Zhou, J., Chen, Q.-M., & Geng, Y.-Q. (2008) · Journal of Virology · doi:10.1128/jvi.02249-07 · Cited by 75
“Other diverse transcription factor families, including the interferon regulatory factor (IRF) (32), the signal transducer and activator of transcription (STAT) (7), the NF- B (15, 16), and the nuclear factor of activated T cells (NFAT) (6) families, can also respond to the external signals in the same way.”
BackgroundHuman primary immunodeficiencies of type I interferons
Jouanguy, E., Zhang, S., Chapgier, A. L. A., Sancho‐Shimizu, V., Puel, A., Pïcard, C., Boisson‐Dupuis, S., Abel, L., & Casanova, J. (2007) · Biochimie · doi:10.1016/j.biochi.2007.04.016 · Cited by 69
Ma, S., Zhang, J., Liu, H., Li, S., & Wang, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.896591 · Cited by 81
Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease
Du, Y., Rong, L., Cong, Y., Shen, L., Zhang, N., & Wang, B. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1901079 · Cited by 81
“The functional characteristics and special tissue distribution of various subtypes of the JAK family have made JAK a new target in the fields of immunity, inflammation, and cancer [156,157].”
BackgroundA Review: Phytochemicals Targeting JAK/STAT Signaling and IDO Expression in Cancer
Arumuggam, N., Bhowmick, N. A., & Rupasinghe, H. P. V. (2015) · Phytotherapy Research · doi:10.1002/ptr.5327 · Cited by 79
“The STAT dimer translocates to the nucleus, where it binds to specific DNA sequences containing gamma activated site motif, and activate transcription (Darnell et al., 1994; Schindler and Darnell, 1995; Darnell, 1997).”
BackgroundInfluentialLee, Y., Park, J., Lee, E.-J., Lee, S., Kim, D., Kang, J. L., & Kim, H.-S. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf506110y · Cited by 77
Ning, Y., Riggins, R. B., Mulla, J. E., Chung, H., Zwart, A. L., & Clarke, R. C. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1169 · Cited by 69
“Once activated by binding IFN, their specific cell membrane receptors activate the Janus-activated kinase–signal transducer and activator of transcription (STAT) pathway, which results in the regulation of IFNstimulated genes, including IRF1 (27, 28).”
BackgroundGazel, A., Rosdy, M., Bertino, B., Tornier, C., Sahuc, F., & Blumenberg, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700461 · Cited by 73
Alternative and Accessory Pathways in the Regulation of IFN-β-Mediated Gene Expression
Rani, M. R. S., & Ransohoff, R. M. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.788 · Cited by 61
“9,10 15 ISGF3 consists of heterooligomers of signal transducers and activators of transcription (Stat)1, Stat2, and the 48-kDa DNA-binding protein, IFN regulatory factor-9 (IRF-9).”
Forget, G., Gregory, D. J., & Olivier, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414126200 · Cited by 71
Yang, Y., Wu, X.-Q., Li, W.-X., Huang, H.-M., Li, H.-D., Pan, X.-Y., Li, X.-F., Huang, C., Meng, X.-M., Zhang, L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0383-0 · Cited by 72
SIRT1 and microRNAs: The role in breast, lung and prostate cancers
Karbasforooshan, H., Roohbakhsh, A., & Karimi, G. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.023 · Cited by 82
Li, Y., Zhang, X., Cui, L., Chen, R., Zhang, Y., Zhang, C., Zhu, X., He, T., Shen, Z., Dong, L., et al. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14140 · Cited by 76
Queval, C. J., Song, O., Deboosère, N., Delorme, V., Debrie, A., Iantomasi, R., Veyron‐Churlet, R., Jouny, S., Redhage, K. R., Deloison, G., et al. (2016) · Scientific Reports · doi:10.1038/srep29297 · Cited by 82
Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer
Suman, S., Sharma, P. K., Rai, G., Mishra, S., Arora, D., Gupta, P., & Shukla, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.133 · Cited by 73
Regulation of Janus kinases by SOCS proteins
Kershaw, N. J., Murphy, J. M., Lucet, I. S., Nicola, N. A., & Babon, J. J. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130077 · Cited by 75
Matsui, F., & Meldrum, K. K. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.06.050 · Cited by 70
Nanoparticle delivery of a peptide targeting EGFR signaling
Kim, S. K., & Huang, L. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.014 · Cited by 75
Morrow, A., Schmeisser, H., Tsuno, T., & Zoon, K. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001359 · Cited by 67
Transmembrane helix-helix interactions involved in ErbB receptor signaling
Cymer, F., & Schneider, D. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.2.11191 · Cited by 81
“Structurally, the receptor consists of an extracellular Epo-binding domain, a single TM helix and an intracellular domain,(20) which is associated with a Janus kinase that mediates downstream signal transduction via the Jak-STAT pathway.(21) Although only the structure of the extracellular EpoR domain with a bound Epo…”
BackgroundHIV-1 Tat Co-Operates with IFN-γ and TNF-α to Increase CXCL10 in Human Astrocytes
Williams, R., Yao, H.-H., Dhillon, N., & Buch, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005709 · Cited by 73
“CXCL10 promoter [44,45,58], however, resulted in abrogation of luciferase expression, thus underscoring the role of each of these”
BackgroundCurcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells
Blasius, R., Reuter, S., Henry, E., Dicato, M. A., & Diederich, M. F. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.029 · Cited by 81
“STAT (signal transducers and activators of transcription) proteins are a family of transcription factors activated by extra-cellular signaling proteins such as cytokines, hormones and growth factors [1–6].”
BackgroundHorinaga, M., Okita, H., Nakashima, J., Kanao, K., Sakamoto, M., & Murai, M. (2005) · Urology · doi:10.1016/j.urology.2005.03.066 · Cited by 73
Yokota, S., Yokosawa, N., Okabayashi, T., Suzutani, T., & Fujii, N. (2005) · Virology · doi:10.1016/j.virol.2005.04.028 · Cited by 67
Contursi, C., Wang, I.-M., Gabriele, L., Gadina, M., O'Shea, J., Morse, H. C., & Ozato, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.91 · Cited by 72
JAK/STAT3 signaling in cardiac fibrosis: a promising therapeutic target
Jiang, H., Yang, J., Li, T., Wang, X., Fan, Z., Ye, Q., & Du, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1336102 · Cited by 68
STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma
Jiang, M., & Li, B. (2022) · Cells · doi:10.3390/cells11193131 · Cited by 78
“The signal transducer and activators of transcription (STAT) family are potential cytoplasmic transcription factors, including STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6, which can be activated in response to cytokine and growth factor stimulation to mediate multiple intracellular signaling pathways [16].”
BackgroundNan, Y.-C., Wang, R., Shen, M., Faaberg, K., Samal, S., & Zhang, Y.-J. (2012) · Virology · doi:10.1016/j.virol.2012.05.015 · Cited by 72
Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR- in Huh-7 cells
Pazienza, V., Vinciguerra, M., Andriulli, A., & Mangia, A. (2010) · Journal of General Virology · doi:10.1099/vir.0.020644-0 · Cited by 69
Gough, D. J., Sabapathy, K., Ko, E. Y.-N., Arthur, H. A., Schreiber, R. D., Trapani, J. A., Clarke, C. J. P., & Johnstone, R. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607674200 · Cited by 62
Robinson, C. M., Hale, P. T., & Carlin, J. M. (2006) · Cytokine · doi:10.1016/j.cyto.2006.07.007 · Cited by 73
“Although latent STAT-1 is activated by tyrosine phosphorylation following binding of IFN-c or TNF-a to their respective receptors, IRF-1 must be synthesized de novo [14–17,25].”
BackgroundGilbert‐Ross, M., Weaver, B. K., Gergen, J. P., & Reich, N. C. (2005) · Mechanisms of Development · doi:10.1016/j.mod.2005.03.004 · Cited by 68
Role of STAT3 in skin fibrosis and transforming growth factor beta signalling
Pedroza, M., To, S., Assassi, S., Wu, M., Tweardy, D. J., & Agarwal, S. K. (2017) · Rheumatology · doi:10.1093/rheumatology/kex347 · Cited by 71
Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics
Kanchi, M. M., Shanmugam, M. K., Rane, G., Sethi, G., & Kumar, A. P. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.08.001 · Cited by 76
IRF9 is a key factor for eliciting the antiproliferative activity of IFN-α
Tsuno, T., Mejido, J., Zhao, T., Schmeisser, H., Morrow, A., & Zoon, K. (2009) · Journal of immunotherapy · doi:10.1097/cji.0b013e3181ad4092 · Cited by 71
“It has been reported that ISREs in most IFN-a response genes are usually located within 200-bp upstream of the TSSs.(19) However, it is also reported that at least 52% of human genes based on reference sequence (National Center for Biotechnology Information) were subject to regulation by putative alternative promoters…”
BackgroundJoshi, S., Kaur, S., Redig, A., Goldsborough, K., David, K. A., Ueda, T., Watanabe‐Fukunaga, R., Baker, D., Fish, E., Fukunaga, R., et al. (2009) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0900562106 · Cited by 71
“Notably, the original discovery of Jak-Stat pathways resulted from work focused on IFN signaling (4, 6, 7) and provided important clues and insights on how IFNs and other cytokines regulate transcription of target genes.”
BackgroundTissue-Specific and Inducer-Specific Differential Induction of ISG56 and ISG54 in Mice
Terenzi, F., White, C. L., Pal, S., Williams, B. R. G., & Sen, G. C. (2007) · Journal of Virology · doi:10.1128/jvi.00322-07 · Cited by 65
“The binding of type I IFNs, IFN- and IFN-, to their cell surface receptor (IFNAR) leads to Jak1- and Tyk2-mediated tyrosine phosphorylation of STAT1 and STAT2, which heterodimerize, bind to IFN regulatory factor 9 (IRF-9, or p48) to form the IFNstimulated gene factor 3 (ISGF3) and translocate to the nucleus ( 8 , 30).”
Background
Metadata
- Authors
- Darnell, J. E., Kerr, L. M., & Stark, G. R.
- Affiliations
- Rockefeller University (US)
- Case Comprehensive Cancer Center (US)
- ORCID
- Stark, George R.
- Venue
- Science
- Published
- 1994-06-03
- Volume
- 264
- Issue
- 5164
- Pages
- 1415-1421
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2029275361
- Cited by
- 6,080
- References
- 85
- Citations by year
- 2026: 84 · 2025: 139 · 2024: 175 · 2023: 170 · 2022: 183 · 2021: 177 · 2020: 162 · 2019: 155 · 2018: 121 · 2017: 166 · 2016: 148 · 2015: 152 · 2014: 160 · 2013: 207 · 2012: 188
- FWCI
- 28.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- JAK/STAT signaling, interferon-alpha, interferon-gamma, signal transduction, STAT proteins, transcriptional activation, JAK kinases, interferon receptor, nuclear translocation, DNA binding
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cell Line, DNA-Binding Proteins, Genes, Genetic Complementation Test, Humans, Interferon-gamma, Molecular Sequence Data, Mutation, Protein-Tyrosine Kinases, Regulatory Sequences, Nucleic Acid, Transcription Factors, Signal Transduction, Transcriptional Activation, Interferon-alpha, Interferon-Stimulated Gene Factor 3, Interferon-Stimulated Gene Factor 3, gamma Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review